Journals / Türk Oftalmoloji Dergisi / 2018 / Cilt: 48 - Sayı: 1

Amniotic Membrane Transplantation in Surgical Treatment of Conjunctival Melanoma: Long-term Results

Pages
15–18
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The use of cryopreservedamniotic membrane for conjunctival defect repair is safe and effective with mild complications, and allows the excision of wider marginsaround the tumor.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate the long-term efficacy and results of surgical management of conjunctival melanoma reconstructed withamniotic membrane transplantation.Materials and Methods: Conjunctival melanoma in 10 patients (5 female, 5 male) was totally excised with adjunctive cryotherapyto the surgical margins, corneal epitheliectomy with absolute alcohol in cases of corneal involvement, lamellar sclerectomy in cases withepiscleral involvement, and ocular surface grafting with cryopreserved amniotic membrane.
📊
Key Findings & Data:Complications and tumor control rates wereevaluated.Results: The mean age of the patients was 57.4±15.2 (range, 37-84) years.
💡
Conclusion & Impact:The use of cryopreservedamniotic membrane for conjunctival defect repair is safe and effective with mild complications, and allows the excision of wider marginsaround the tumor.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To investigate the long-term efficacy and results of surgical management of conjunctival melanoma reconstructed withamniotic membrane transplantation.Materials and Methods: Conjunctival melanoma in 10 patients (5 female, 5 male) was totally excised with adjunctive cryotherapyto the surgical margins, corneal epitheliectomy with absolute alcohol in cases of corneal involvement, lamellar sclerectomy in cases withepiscleral involvement, and ocular surface grafting with cryopreserved amniotic membrane. Complications and tumor control rates wereevaluated.Results: The mean age of the patients was 57.4±15.2 (range, 37-84) years. The mean diameter of the tumors was 15.5±4.9 (range, 10-25) mm and histopathologically confirmed complete excision was performed in all cases. Mild limbal stem cell deficiency (2 eyes) andsubclinical symblepharon (3 eyes) were observed as long-term complications. In a mean follow-up of 56.7±40.4 (range, 30-132) months,only one local tumor recurrence was detected. Despite retreatment, exenteration was performed in this patient due to re-recurrence. Onepatient died due to disseminated metastasis despite the absence of local recurrence.Conclusion: In large conjunctival melanomas, reconstruction of the ocular surface is usually very challenging. The use of cryopreservedamniotic membrane for conjunctival defect repair is safe and effective with mild complications, and allows the excision of wider marginsaround the tumor.

🔖

Cite This Article

AKALIN, T., YAMAN, B., PALAMAR, M., YAĞCI, A. (2022). Amniotic Membrane Transplantation in Surgical Treatment of Conjunctival Melanoma: Long-term Results. Türk Oftalmoloji Dergisi, Cilt: 48 - Sayı: 1, 15–18. https://ajindex.com/articles/637790

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Meller D, Dabul V, Tseng SC. Expansion of conjunctival epithelial progenitor cells on amniotic membrane. Exp Eye Res. 2002;74:537-545.
  2. Barabino S, Rolando M. Amniotic membrane transplantation elicits goblet cell repopulation after conjunctival reconstruction in a case of severe ocular cicatricial pemphigoid. Acta Ophthalmol Scand. 2003;81:68-71.
  3. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19:348-352.
  4. Tseng SC, Li DQ, Max X. Suppression of transforming growth factor-beta isoforms, TGF-β receptor II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179:325-335.
  5. Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC. Suppression of TGF β signalling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res. 2000;20:325-334.
  6. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173-177.
  7. Grueterich M, Tseng SCG. Human limbal progenitor cells expanded on intact amniotic membrane ex-vivo. Arch Ophthalmol. 2002;120:783-790.
  8. Dua HS, Gomes JA, Kinng AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49:51-77.
  9. Gündüz K, Ucakhan OO, Kanpolat A, Gunalp I. Nonpreserved human amniotic membrane transplantation for conjunctival reconstruction of extensive ocular surface neoplasias. Eye (Lond). 2006;20:351-357.
  10. Palamar M, Kaya E, Egrilmez S, Akalin T, Yagci A. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye (Lond). 2014;28:1131-1135.
  11. Shields CL, Kaliki S, Al-Daamash SA, Lally SE, Shields JA. American Joint Committee on Cancer (AJCC) Clinical Classification Predicts Conjunctival Melanoma Outcomes. Ophthal Plast Reconstr Surg. 2012;5:313-323.
  12. Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol. 1997;115:808-815.
  13. Azuaro-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol. 1999;83:399-402. AJCC Cancer Staging Manual (8th ed). Switzerland; Springer; 2017:795-803.
  14. Dalla Pozza G, Ghirlando A, Busato F, Midena E. Reconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: a long-